Press release
2025 Cardiac Biomarkers Testing Industry Trends Report: Long-Term Outlook Through 2034
Cardiac Biomarkers Testing Market
How Large Will the Cardiac Biomarkers Testing Market Size By 2025?
Over the past few years, the market size for cardiac biomarkers testing has expanded at a brisk pace. It is projected to rise from a value of $13.48 billion in 2024 to a substantial $14.95 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.9%. Factors that have contributed to the historic period's surge include a rise in cardiovascular diseases, an aging population, initiatives for education and awareness, official policies and initiatives in healthcare, along with a growing budget for healthcare expenditures.
How Big Is the Cardiac Biomarkers Testing Market Size Expected to Grow by 2029?
In the coming years, rapid expansion is anticipated in the cardiac biomarkers testing market, with projections indicating a growth to "$23.24 billion in 2029 at a compound annual growth rate (CAGR) of 11.7%. The predicted surge during the forecast period can be attributed to elements such as personalized healthcare, the escalating global incidence of cardiovascular diseases, the incorporation of artificial intelligence (AI) in diagnostic procedures, the proliferation of point-of-care testing, and an increased focus on early disease detection. Key trends forecasted for this period include technological progression, developments in AI-assisted diagnostics, growth in point-of-care testing (POCT), expansion of multiplexing capabilities, and the discovery and validation of biomarkers.
View the full report here:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Which Key Market Drivers Powering Cardiac Biomarkers Testing Market Expansion and Growth?
The escalating occurrence of cardiovascular diseases is projected to fuel the expansion of the cardiac biomarkers testing market in the future. Cardiovascular diseases entail conditions involving the heart and the circulatory system. Cardiac biomarker tests are essential in diagnosing the severity and the scale of a heart attack promptly through determining biomarker levels. Therefore, an upswing in cardiovascular disease prevalence will in turn trigger a surge in demand for cardiac biomarker testing solutions. As an example, per the American College of Cardiology, a professional medical organization based in the U.S., it is predicted that the rates of cardiovascular risk factors and the disease itself will significantly escalate in the US by 2060. Thus, the mounting prevalence of cardiovascular diseases is fueling the growth of the cardiac biomarkers testing market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
What Are the Key Trends Driving Cardiac Biomarkers Testing Market Growth?
Leading firms in the cardiac biomarker testing market are leveraging strategic alliances to equip technology for early detection of heart disease indicators and to enhance patient results. Such alliances in the cardiac biomarker testing space inspire cooperation among companies, leading to the creation of novel diagnostics, widening market access, and fast-tracking the presence of advanced testing methods for improved heart care. For example, in September 2024, MediBuddy, a health technology company from India offering a complete telemedicine platform along with health management and insurance support, teamed up with Philips, a multinational corporation based in the Netherlands. The alliance intends to elevate cardiac care in India by infusing Philips' HeartPrint technology, thereby facilitating regular monitoring and risk evaluation for heart conditions. This visionary strategy equips MediBuddy platform's users with state-of-the-art tools, thereby instigating a proactive approach towards heart health management and better outcome realization.
What Are the Emerging Segments in the Cardiac Biomarkers Testing Market?
The cardiac biomarkers testing market covered in this report is segmented -
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Subsegments:
1) By Creatine Kinase (CK-MB): Total CK-MB, CK-MB Mass
2) By Troponins: Cardiac Troponin I (cTnI), Cardiac Troponin T (cTnT)
3) By Myoglobin: Total Myoglobin
4) By Natriuretic Peptides: B-Type Natriuretic Peptide (BNP), N-Terminal Pro B-Type Natriuretic Peptide (NT-ProBNP)
5) By Ischemia Modified Albumin (IMA): IMA Levels
6) By Other Biomarkers Types: C-Reactive Protein (CRP), Heart-Type Fatty Acid-Binding Protein (H-FABP), Soluble ST2
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp
Who Are the Global Leaders in the Cardiac Biomarkers Testing Market?
Major companies operating in the cardiac biomarkers testing market include Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton dic*kinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation
Which are the Top Profitable Regional Markets for the Cardiac Biomarkers Testing Industry?
North America was the largest region in the cardiac biomarkers testing market in 2024. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9436
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 2025 Cardiac Biomarkers Testing Industry Trends Report: Long-Term Outlook Through 2034 here
News-ID: 4180350 • Views: …
More Releases from The Business Research Company
2025 Lyophilized Injectable Drugs Market Outlook: Key Indicators Shaping Growth …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Lyophilized Injectable Drugs Industry Market Size Be by 2025?
The market size for lyophilized injectable drugs has been consistently expanding in the past few years. The market is projected to increase from $3.92 billion in 2024 to $4 billion in 2025, with a compound annual growth…
Rising Arthritis Prevalence Fuels Expansion Of Generic Musculoskeletal Disorders …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Generic Musculoskeletal Disorders Drugs Market Through 2025?
The market size for generic drugs treating musculoskeletal disorders has seen significant growth in the past few years. The market projections show an increase from $0.06 billion in 2024 to $0.06 billion in 2025, boasting…
Major Growth Driver Identified in 2025 Inhalable Drugs Market: Surge In Respirat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Inhalable Drugs Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market for inhalable medications has been expanding robustly over the past few years. Its size is projected to rise from $35.06 billion in 2024 to $36.91 billion in 2025, indicating a compound annual growth…
Future of the Empty Capsules Market: Trends, Innovations, and Key Forecasts Thro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Empty Capsules Market Size Growth Forecast: What to Expect by 2025?
The market size for empty capsules has witnessed a robust growth in the recent past. The market value is projected to escalate from $3.21 billion in 2024 to $3.47 billion in 2025, with a compound annual growth rate…
More Releases for Cardiac
Cardiac Resynchronization Therapy: Driving Innovation and Transforming Global Ca …
London, UK - August 2025 | Strategic Revenue Insights Inc. The global cardiac resynchronization therapy (CRT) market is emerging as one of the most crucial sectors in cardiovascular healthcare, offering life-saving solutions for patients with heart failure and conduction abnormalities. CRT devices, including pacemakers and defibrillators, are designed to restore synchronized heart contractions, significantly improving patient survival rates and quality of life. With rising cardiovascular disease prevalence worldwide, CRT has…
Mobile Cardiac Telemetry Systems Market Redefining Remote Cardiac Monitoring
"In recent years, the global Mobile Cardiac Telemetry Systems Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Mobile Cardiac Telemetry Systems Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot…
Ambulatory Cardiac Monitoring Devices Market: Revolutionizing Cardiac Care
In the rapidly evolving landscape of healthcare, the Ambulatory Cardiac Monitoring Devices Market stands out as a beacon of innovation and progress. These devices, including ECG devices, Holter monitors, event monitors, implantable loop recorders, and mobile cardiac telemetry, have become indispensable tools for healthcare professionals in managing and diagnosing cardiac conditions. As heart-related issues continue to afflict millions globally, the demand for advanced cardiac monitoring solutions is on the rise.
Request…
Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Precision Monito …
Newark, New Castle, USA: The "Cardiac Monitoring & Cardiac Rhythm Management Devices Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cardiac Monitoring & Cardiac Rhythm Management Devices…
Cardiac Monitoring & Cardiac Rhythm Management Device Market
According to a new market research report published by Global Market Estimates, the Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market is expected to grow at a CAGR of 3.88% during the forecast period. The increasing occurrence of dyslipidemia, hypertension, and rising demand for cardiac monitoring & cardiac rhythm management devices to save patients at a huge risk of cardiac arrest.
Browse 145 Market Data Tables and 119 Figures spread…
Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,…
